These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1904114)

  • 41. Role of central dopaminergic and 5-hydroxytryptaminergic projections in the behavioral responses elicited by thyrotropin-releasing hormone in rats.
    Funk D; Post RM; Pert A
    Psychopharmacology (Berl); 1997 Oct; 133(4):356-62. PubMed ID: 9372535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of TA-0910, an orally active TRH analog, on the spinal reflex in spinal rats.
    Kinoshita K; Nagao T; Ono H
    Neuropharmacology; 1994 Oct; 33(10):1183-8. PubMed ID: 7862253
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of a new TRH analogue, YM-14673, on spontaneous motor activity in rats.
    Shimizu M; Yamamoto M; Kobayashi M
    Arch Int Pharmacodyn Ther; 1989; 301():100-11. PubMed ID: 2516440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum.
    Kerkerian L; Dusticier N; Nieoullon A
    J Neurochem; 1987 Apr; 48(4):1301-6. PubMed ID: 2880932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioural and biochemical evidence for the release of noradrenaline in mouse brain by TRH and some of its biologically stable analogues.
    Heal DJ; Stoodley N; Elliott JM; Marsden CA; Bennett GW; Youdim MB
    Neuropharmacology; 1987 Apr; 26(4):313-22. PubMed ID: 2884590
    [TBL] [Abstract][Full Text] [Related]  

  • 46. delta 9-Tetrahydrocannabinol elicited ipsilateral circling behavior in rats with unilateral nigral lesion.
    Sakurai Y; Ohta H; Shimazoe T; Kataoka Y; Fujiwara M; Ueki S
    Life Sci; 1985 Dec; 37(23):2181-5. PubMed ID: 2999542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval.
    Castro R; Abreu P; Calzadilla CH; Rodriguez M
    Psychopharmacology (Berl); 1985; 85(3):333-9. PubMed ID: 3923520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progressive augmentation of locomotor activity in mice by long-term treatment with thyrotropin releasing hormone.
    Ushijima I; Yamada K; Noda Y; Furukawa T
    Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):29-37. PubMed ID: 6437352
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of acute and long-term treatments with thyrotropin-releasing hormone on locomotor activity and jumping behavior in mice.
    Ushijima I; Mizuki Y; Hara T; Watanabe K; Hirano H; Yamada M; Glavin GB
    Pharmacol Biochem Behav; 1986 May; 24(5):1423-8. PubMed ID: 3088609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A; Nieoullon A; Amalric M
    Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circling behavior in normoxic or hypoxic rats with unilateral 6-OHDA nigrostriatal lesion. Part 1. Effects of apomorphine and L-dopa.
    Saligaut C; Daoust M; Moore N; Boismare F
    Methods Find Exp Clin Pharmacol; 1987 Apr; 9(4):219-24. PubMed ID: 3110513
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo evaluation by differential pulse voltammetry of the effect of thyrotropin-releasing hormone (TRH) on dopaminergic and serotoninergic synaptic activity in the striatum and nucleus accumbens of the rat.
    Crespi F; Keane PE; Morre M
    Exp Brain Res; 1986; 62(2):329-34. PubMed ID: 2423357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.
    Blunt S; Jenner P; Marsden CD
    Neuroscience; 1991; 40(2):453-64. PubMed ID: 1902916
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Functional validation of projection topography in the nigrostriatal dopamine system.
    Redgrave P; Mitchell I
    Neuroscience; 1982 Apr; 7(4):885-94. PubMed ID: 6808415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lesion-induced DA supersensitivity in aging C57BL/6J mice.
    Randall PK
    Brain Res; 1984 Aug; 308(2):333-6. PubMed ID: 6434153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones.
    Kelly E; Jenner P; Marsden CD
    Neurosci Lett; 1985 May; 56(1):57-62. PubMed ID: 4011049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repeated administration of triiodothyronine (T3) to rats enhances nigrostriatal and mesolimbic dopaminergic behavioural responses.
    Heal DJ; Atterwill CK
    Neuropharmacology; 1982 Feb; 21(2):159-62. PubMed ID: 7063110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tolerance to the serotonin 5-HT1 agonist RU 24969 and effects on dopaminergic behaviour.
    Oberlander C; Demassey Y; Verdu A; Van de Velde D; Bardelay C
    Eur J Pharmacol; 1987 Jul; 139(2):205-14. PubMed ID: 2443369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog, (I): Effects on the central nervous system by oral administration.
    Yamamura M; Kinoshita K; Nakagawa H; Tanaka T; Maeda K; Ishida R
    Jpn J Pharmacol; 1990 Aug; 53(4):451-61. PubMed ID: 2120494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Behavioural effects in the rat after acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sirinathsinghji DJ
    Brain Res; 1985 Jul; 339(2):366-70. PubMed ID: 3928091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.